Age, energy IWHS, intake, height, 212/ Bostick, 1994 Prospective parity, vitamin a Superseded by 35 216 Incidence, colon 1.25 (0.83-1.88) COL00079 Cohort, SEER Self-reported vs supplement, Folsom, 2000 ≥0.91 ≤0.76 167 447 cancer Ptrend:0.30 USA Age: 55-69 vitamin intake, COL01688 W vitamin e intake age IWHS, Prospective 212/ Bostick, 1993 Cohort, 35 216 Incidence, Mean exposure COL00483 SEER Self-reported 0.84 Age: 55-69 167 447 cancer reported USA years, years W IWHS, Prospective 212/ Bostick, 1993 Cohort, 35 216 Incidence, colon Mean exposure COL01450 SEER Self-reported Age: 55-69 167 447 cancer reported USA years, W Cardiovascular Health Study, Schoen, 1990 Prospective 102/ Incidence, Age, sex, Used in HvsL COL00183 Hospital record Measured Q4 vs Q1 2.6 (1.4-4.8) Cohort, 5 849 cancer physical activity analysis USA Age: >65
years Bostick, 1994 COL00079 USA IWHS, Prospective Cohort, Age: 55-69 W 212/ 35 216 167 447 SEER Self-reported Incidence, colon cancer ≥0.91 vs ≤0.76 1.25 (0.83-1.88) Ptrend:0.30 Age, energy intake, height, parity, vitamin a supplement, vitamin intake, vitamin e intake age Superseded by Folsom, 2000 COL01688 Bostick, 1993 COL00483 USA IWHS, Prospective Cohort, Age: 55-69 years, W 212/ 35 216 167 447 SEER Self-reported Incidence, cancer 0.84 Mean exposure reported Bostick, 1993 COL01450 USA IWHS, Prospective Cohort, Age: 55-69 years, W 212/ 35 216 167 447 SEER Self-reported Incidence, colon cancer Mean exposure reported Schoen, 1990 COL00183 USA Cardiovascular Health Study, Prospective Cohort, Age: >65 102/ 5 849 Hospital record Measured Incidence, cancer Q4 vs Q1 2.6 (1.4-4.8) Age, sex, physical activity Used in HvsL analysis
CUP_colorectal_SLR_2016_RO.docx